Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Northrop Grumman | NOC | Nov 22, 2024 | 496.87 | +0.09 |
NorthView Acquisition | NVAC | Nov 22, 2024 | 11.71 | 0.00 |
Northwest Bancshares | NWBI | Nov 22, 2024 | 14.93 | +2.05 |
Northwest Natural Holdings | NWN | Nov 22, 2024 | 43.78 | +1.32 |
Northwest Pipe | NWPX | Nov 22, 2024 | 56.29 | +1.96 |
NorthWestern Energy | NWE | Nov 22, 2024 | 56.75 | +0.42 |
Norwegian Cruise Line | NCLH | Nov 22, 2024 | 26.86 | +0.37 |
Norwood Financial | NWFL | Nov 22, 2024 | 30.51 | +2.28 |
Notable Labs | NTBL | Nov 22, 2024 | 0.34 | 0.00 |
Nouveau Monde Graphite | NMG | Nov 22, 2024 | 1.26 | +0.80 |
NOV | NOV | Nov 22, 2024 | 16.61 | +1.28 |
Nova | NVMI | Nov 22, 2024 | 179.76 | +0.02 |
Nova Lifestyle | NVFY | Nov 22, 2024 | 0.61 | +2.40 |
Nova Minerals | NVA | Nov 22, 2024 | 8.16 | +1.49 |
Nova Vision Acquisition | NOVV | Nov 22, 2024 | 37.00 | 0.00 |
Novabay Pharmaceuticals | NBY | Nov 22, 2024 | 0.68 | -5.39 |
Novagold Resources | NG | Nov 22, 2024 | 3.65 | +1.39 |
Novanta | NOVT | Nov 22, 2024 | 169.79 | +3.08 |
Novartis ADR | NVS | Nov 22, 2024 | 104.28 | +0.41 |
Novavax | NVAX | Nov 22, 2024 | 8.47 | +5.35 |
Novo Integrated Sciences | NVOS | Nov 22, 2024 | 0.17 | 0.00 |
Novo Nordisk ADR | NVO | Nov 22, 2024 | 105.06 | +2.37 |
NovoCure | NVCR | Nov 22, 2024 | 17.73 | +3.74 |
Novonix ADR | NVX | Nov 22, 2024 | 1.93 | +0.52 |
NRG Energy | NRG | Nov 22, 2024 | 95.48 | -1.46 |
NRx Pharmaceuticals | NRXP | Nov 22, 2024 | 1.26 | +2.44 |
NSTS Bancorp | NSTS | Nov 22, 2024 | 11.24 | +0.45 |
Nu Holdings | NU | Nov 22, 2024 | 13.91 | +3.81 |
Nu Skin Enterprises | NUS | Nov 22, 2024 | 7.22 | -1.10 |
Nuburu | BURU | Nov 22, 2024 | 0.47 | +2.50 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.